Effects of natriuretic peptides on the mechanisms of atherosclerosis

利钠肽对动脉粥样硬化机制的影响

基本信息

  • 批准号:
    05670622
  • 负责人:
  • 金额:
    $ 1.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1994
  • 项目状态:
    已结题

项目摘要

Neutral Endopeptidase 24.11 (NEP), widely distributed in the body, hydrolyzes and inactivates a number of endogenous vasoactive peptides, some of which could alter the functions of smooth muscle cell or macrophage in the arterial wall. The aim of this study was to assess the influence of chronic NEP inhibition by daily administration of UK79300 (Candoxatril ; UK), an orally active inhibitor of NEP,on the development of atherosclerotic changes in high cholesterol-fed rabbits. Male New Zealand White rabbits were fed for 8 weeks : normal rabbit diet (Nor, n=15), 1.5% cholesterol diet (Chol, n=15), or 1.5% choresterol diet containing UK (20 mg/kg/day) (UK +Chol, n=15). At the end of dietary period, UK-treatment suppressed surface area of the aorta covered by plaques (% surface area : Chol 48 + 7% vs UK + chol 11 + 3, p<0.05) and decreased contents of cholesterol and cholesterol ester in the aortas. UK also reduced plasma total cholesterol by 15 + 4% of Chol (1680 + 180 mg/dl). UK-treatment preserved endothelium-dependent relaxation of the isolated thoracic aortic rings suspended in the organ chamber in response to acetylcholine (ACh) (EC50, nM ; concentrations of ACh causing 50% inhibition of contractions with 0.3 mM of phenylephrine : Nor 12 + 4, Chol 360 + 20 +, UK + Chol 56 + 9^*, +p<0.01 vs Nor, ^*p<0.01 vs Chol). UK-treatment decreased plasma NEP enzymatic activity by 27 + 3% of Chol and prevented the atherosclerotic impairment of relaxation of the isolated thoracic aortic rings in the organ chamber in response to atrial natriuretic peptide, one of NEP substrates (EC50, pM : Nor 50 + 4, Chol 290 + 20 +, UK + Chol 65 + 8, +p<0.01 vs Nor, ^*p<0.01 vs Chol). The results suggest that NEP plays a significant role in atherogenesis and NEP inhibitors might be therapeutically useful in the prevention of atherosclerosis.
中性内肽酶24.11(NEP)广泛分布于体内,能对多种内源性血管活性多肽进行降解和失活,其中一些内源性血管活性多肽可以改变动脉壁中的平滑肌细胞或巨噬细胞的功能。本研究的目的是评价口服NEP活性抑制剂UK79300(Candoxtril;UK)对高胆固醇喂养兔动脉粥样硬化形成的影响。雄性新西兰大白兔饲喂8周:正常兔饲料(NOR,n=15)、1.5%胆固醇饲料(Chol,n=15)或含UK的1.5%Choresterol饲料(20 mg/kg/d)(UK+Chol,n=15)。在饲粮结束时,UK处理组大鼠的主动脉表面积被斑块覆盖(%表面积:Chol 48±7%vs UK+Chol 11+3,p&lt;0.05),并降低了主动脉中胆固醇和胆固醇酯的含量。UK还将血浆总胆固醇降低了15+4%的Chol(1680+180 mg/dl)。UK处理保留了对乙酰胆碱(ACh)(EC50,NM;0.3 mM苯肾上腺素可抑制50%收缩的ACh浓度:NOR 12+4,Chol 360+20+,UK+Chol 56+9^*,+p&lt;0.01vs Nor,^*p&lt;0.01vs Chol)的血管内皮依赖性的松弛作用。UK处理使血浆NEP酶活性降低27+3%,并防止心钠素(NEP底物之一,EC50,PM:NOR 50+4,Chol 290+20+,UK+Chol 65+8,+p&lt;0.01vs Nor,^*p&lt;0.01vs Chol)对器官腔内离体胸主动脉环松弛的动脉粥样硬化损害。结果提示,NEP在动脉粥样硬化形成中起重要作用,NEP抑制剂可能在预防动脉粥样硬化方面有一定的应用价值。

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hirofumi Yasue: "Localization and Mechanisms of Secretion of B-type Natriuretic Peptide(BNP)in Comparison Peptide(ANP)in Normal Subjects and Patients With Heart Failure" Circulation. 90. 195-203 (1994)
Hirofumi Yasue:“正常受试者和心力衰竭患者的比较肽(ANP)中 B 型钠尿肽(BNP)分泌的定位和机制”循环。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hirofumi Yasue, Kiyotaka Kugiyama, et al.: "Localization and mechanisms of secretion of B-type natriuretic peptide (BNP) in comparison with those of A-type natriuretic peptide (ANP) in normal subjects and patients with heart failure." Circulation. 90. 195
Hirofumi Yasue、Kiyotaka Kugiyama 等人:“在正常受试者和心力衰竭患者中,与 A 型利钠肽 (ANP) 相比,B 型利钠肽 (BNP) 的定位和分泌机制。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Seigo Sugiyama: "Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothe-lial dysfunction in porcine coronary arteries:role of protein kinase C" Circulation Research.
Seigo Sugiyama:“氧化低密度脂蛋白中的溶血磷脂酰胆碱增加了猪冠状动脉内皮对多形核白细胞诱导的内皮功能障碍的敏感性:蛋白激酶 C 的作用”循环研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Toyoaki Murohara: "Cigarette Smoke Extract Contracts Isolated Porcine Coronary Arteries by Superoxide Anion-mediated Degradation of EDRF" Am J Physiol. 266. H874-H880 (1994)
Toyoaki Murohara:“香烟烟雾提取物通过超氧阴离子介导的 EDRF 降解使离体猪冠状动脉收缩”Am J Physiol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Toyoaki Murohara, Kiyotaka Kugiyama, et al.: "LPC in oxidized LDL elicits vasoconstriction and inhibits endothelium - dependent relaxation." Am J Physiol. 267. H2441-H2449 (1994)
Toyoaki Murohara、Kiyotaka Kugiyama 等人:“氧化 LDL 中的 LPC 会引起血管收缩并抑制内皮依赖性松弛。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUGIYAMA Kiyotaka其他文献

KUGIYAMA Kiyotaka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUGIYAMA Kiyotaka', 18)}}的其他基金

A study of role of phospholipase A2 receptor in pathogenosis ofcardiovascular diseases and development of new drug for cardiovascular diseases
磷脂酶A2受体在心血管疾病发病机制中的作用研究及心血管疾病新药开发
  • 批准号:
    22390158
  • 财政年份:
    2010
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A study of role of phospholipase A2 in pathogenosis of cardiovascular diseases and development of new drug for cardiovascular diseases
磷脂酶A2在心血管疾病发病中的作用研究及心血管疾病新药开发
  • 批准号:
    19390209
  • 财政年份:
    2007
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Clinical significance of remnant lipoproteinemia as a therapeutic target of cardiovascular diseases
残余脂蛋白血症作为心血管疾病治疗靶点的临床意义
  • 批准号:
    15390244
  • 财政年份:
    2003
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of polymorphisms of γ-glutamylcysteine synthetase genes in pathogenesis of coronary spastic angina
γ-谷氨酰半胱氨酸合成酶基因多态性在冠状动脉痉挛性心绞痛发病机制中的作用
  • 批准号:
    13670728
  • 财政年份:
    2001
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of oxidative stress in pathogenesis of coronary spasm, a molecular biological and clinical study
氧化应激在冠状动脉痉挛发病机制中的作用,分子生物学和临床研究
  • 批准号:
    11670693
  • 财政年份:
    1999
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of remnant lipoproteins on functions of endothelial cells, smooth muscle
残余脂蛋白对内皮细胞、平滑肌功能的影响
  • 批准号:
    09670730
  • 财政年份:
    1997
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of lysolecithin on the regulation of gene transcription in endothelial cells and plasma levels of secretary type II phospholipase A2 in coronary artery disease
溶血卵磷脂对冠心病内皮细胞基因转录及血浆分泌型II型磷脂酶A2水平的影响
  • 批准号:
    07670793
  • 财政年份:
    1995
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of oxidized low density lipoprotein on vascular endothelial and smooth muscle cells
氧化低密度脂蛋白对血管内皮和平滑肌细胞的影响
  • 批准号:
    03670460
  • 财政年份:
    1991
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Novel Interplay between the Apelin Pathway and Neutral Endopeptidase in Heart Disease
Apelin 通路与中性肽链内切酶在心脏病中的新相互作用
  • 批准号:
    407964
  • 财政年份:
    2019
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Operating Grants
NEUTRAL ENDOPEPTIDASE INACTIVATION IN ADVANCED PROSTATE
晚期前列腺中的中性内肽酶失活
  • 批准号:
    2896750
  • 财政年份:
    1998
  • 资助金额:
    $ 1.41万
  • 项目类别:
Neutral Endopeptidase inactivation in advanced prostate
晚期前列腺中的中性肽链内切酶失活
  • 批准号:
    6607210
  • 财政年份:
    1998
  • 资助金额:
    $ 1.41万
  • 项目类别:
Neutral Endopeptidase inactivation in advanced prostate
晚期前列腺中的中性肽链内切酶失活
  • 批准号:
    6894775
  • 财政年份:
    1998
  • 资助金额:
    $ 1.41万
  • 项目类别:
Neutral Endopeptidase inactivation in advanced prostate
晚期前列腺中的中性肽链内切酶失活
  • 批准号:
    6547988
  • 财政年份:
    1998
  • 资助金额:
    $ 1.41万
  • 项目类别:
NEUTRAL ENDOPEPTIDASE INACTIVATION IN ADVANCED PROSTATE
晚期前列腺中的中性内肽酶失活
  • 批准号:
    6377014
  • 财政年份:
    1998
  • 资助金额:
    $ 1.41万
  • 项目类别:
Development of the dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase as the drugs of chronic heart failure
血管紧张素转换酶和中性内肽酶双重抑制剂治疗慢性心力衰竭药物的研制
  • 批准号:
    10557226
  • 财政年份:
    1998
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Neutral Endopeptidase inactivation in advanced prostate
晚期前列腺中的中性肽链内切酶失活
  • 批准号:
    6768847
  • 财政年份:
    1998
  • 资助金额:
    $ 1.41万
  • 项目类别:
NEUTRAL ENDOPEPTIDASE INACTIVATION IN ADVANCED PROSTATE
晚期前列腺中的中性内肽酶失活
  • 批准号:
    6173778
  • 财政年份:
    1998
  • 资助金额:
    $ 1.41万
  • 项目类别:
NEUTRAL ENDOPEPTIDASE INACTIVATION IN ADVANCED PROSTATE
晚期前列腺中的中性内肽酶失活
  • 批准号:
    2761230
  • 财政年份:
    1998
  • 资助金额:
    $ 1.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了